Article info

PDF
Ruthenium-106 brachytherapy for iris and iridociliary melanomas

Authors

  1. Correspondence to Dr Marina Marinkovic, Department of Ophthalmology and Melanoma Center, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands; m.marinkovic{at}lumc.nl
View Full Text

Citation

Marinkovic M, Horeweg N, Laman MS, et al
Ruthenium-106 brachytherapy for iris and iridociliary melanomas

Publication history

  • Received May 22, 2017
  • Revised October 23, 2017
  • Accepted October 26, 2017
  • First published November 9, 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.